Robert E. Sievers

Analytical chemistry, pharmaceutical science, aerosols, microparticles and nanoparticles, supercritical fluids, and thin film deposition

Professor - Chemistry and Biochemistry ; Core faculty - Environmental Studies Program ; Fellow - Cooperative Institute for Research in Environmental Sciences

Ph.D. 1960 University of Illinois

Contact

.(JavaScript must be enabled to view this email address)

303-492-7943

Home Page

CU-Boulder Environmental Program

Chemistry and Biochemistry

Cooperative Institute for Research in Environmental Sciences

ENVS Graduate Program - Secondary Core prior to Fall 2012

More Info

Administration

Director of CU-Boulder Environmental Program.

Research Details

Fundamental and applied studies of the formation of nanoparticle and microparticle aerosols are underway. Carbon dioxide-assisted nebulization provides superior aerosols for various forms of spectroscopy, such as electro-spray ionization, mass spectrometry and atomic absorption. Sievers' students are collaborating with pharmacists and physicians in the University of Colorado Health Sciences Center of Pharmaceutical Biotechnology, to develop new methods for delivery of aerosol particles useful in direct and painless administration of therapeutic drugs by inhalation. The drugs are dissolved or suspended in supercritical fluids, and unusually small aerosol particles are formed by rapid decompression to facilitate delivery of the aerosol particles to the most distal alveoli and to allow rapid uptake by the lungs. Formation of fine aerosols is expected to become increasingly important in the treatment or vaccination against influenza, infections, cystic fibrosis, asthma, and diabetes.

The simultaneous stabilization , drying, and micronization of vaccines, antibodies, proteins, antibiotics, and anti-inflammatory pharmaceuticals and other products of the biotechnology revolution are under study. Two of the fourteen “Grand Challenges” identified by the Gates Foundation and the NIH Foundation as critical to world health are being addressed by the Sievers group: needle-free administration of vaccines (by pulmonary or nasal aerosols), and vaccines that do not need refrigeration for long term storage.

Coatings of many materials can be deposited on complex surfaces and on particles from 70 nm to 30,00 nm by CAN-BD, a process patented by the Sievers group.

October 20 2011

Robert Sievers: Developing a Dried Powder Inhalant Vaccine

March 15 2011

The man fighting measles one breath at a time

February 18 2009

Gov. Ritter Honors Life-Saving Impact of CU-Boulder Inhalable Vacci

January 13 2009

Professor Bob Sievers receives 2008 ACS Astellas Award.